It’s a known fact that Microsoft Corporation MSFT co-founder Bill Gates, through his Bill & Melinda Gates Foundation, he works to eradicate infectious disease and poverty in developing and underdeveloped countries.

Gates took to Twitter this week to share details of another disease he’s working to combat.

“We are announcing the second phase of @TheADDF’s diagnostic accelerator,” he said.

“I am confident that this new phase will make advances that will help change the course of Alzheimer’s disease.”

We are announcing the second phase of @TheADDF‘s diagnostic accelerator. I am hopeful that this new phase will make advances that will help change the course of Alzheimer’s. https://t.co/VwsdNDsBDf

— Bill Gates (@BillGates) July 28, 2022

The Alzheimer’s Drug Discovery Foundation (ADDF) launched the Diagnostics Accelerator in 2018 with inaugural funding from Gates, Estee Lauder Companies Inc el Leonard Lauder, Amazon, Inc. AMZN founder jeff bezos and the Dolby family. The project aims to make Alzheimer’s testing affordable, as the existing tests are expensive and invasive.

Related link: The Alzheimer’s drug pipeline: High failure rates in research on an increasingly common disease

“The goal is to develop reliable and affordable biomarker tests, just as cholesterol is recognized as an early biomarker of heart disease risk,” ADDF said on its website.

All of this is critical to developing effective preventive and curative treatments for Alzheimer’s, she added. Diagnostics Accelerator has now received an additional $50 million in funding commitments from new donors including the NFL Players Association, Eli Lilly & Co LLY, Biogen, Inc. BIIB and the Shanahan Family Foundation. This brings total funding received since 2018 to $100 million.

Effective treatments for Alzheimer’s, a neurological disease, have eluded researchers because it is difficult to diagnose the disease at an early stage…